Telomeres are specialised structures at the ends of mammalian chromosomes with many unique properties. Recombinational events at telomeres are more frequent than in the remainder of the genome by several orders of magnitude. This study examined the influence of telomerase status and telomere length on genome-wide recombination assessed by genomic sister chromatid exchange (G-SCE). Telomerase deficiency per se appears to increase G-SCE frequencies in splenocytes but as telomeres shorten through subsequent generations of mTerc–/– mice this increase is progressively lost. Telomerase status and telomere length also influences the induction of G-SCE by UV light. Even when mitotic recombination is affected by PARP deficiency, mTerc and telomere length interact to further affect G-SCE frequencies. Taken together the data presented here demonstrate that telomerase status and telomere length can affect recombination frequencies genome-wide.

1.
Alves P, Jonasson J: New staining method for the detection of sister-chromatid exchanges in BrdU-labelled chromosomes. J Cell Sci 32:185–195 (1978).
2.
Bailey SM, Cornforth MN, Karimasa A, Chen DJ, Goodwin EH: Strand-specific postreplicative processing of mammalian telomeres. Science 293:2462–2465 (2001).
3.
Bailey SM, Brenneman MA, Goodwin EH: Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res 32:3743–3751 (2004).
4.
Bechter OE, Zou Y, Shay JW, Wright WE: Homologous recombination in human telomerase positive and ALT cells occurs with the same frequency. EMBO Rep 4:1138–1143 (2003).
5.
Bechter OE, Zou Y, Walker W, Wright WE, Shay JW: Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res 64:3444–3451 (2004).
6.
Benetti R, Garcia-Cao M, Blasco MA: Telomere length regulates the epigenetic status of mammalian telomeres and sub-telomeres. Nat Genet 39:243–250 (2007a).
7.
Benetti R, Gonzalo S, Jaco I, Schotta G, Klatt P, et al: Suv4-20h deficiency results in telomere elongation and depression of telomere recombination. J Cell Biol 178:925–936 (2007b).
8.
Benetti R, Gonzalo S, Jaco I, Muñoz P, Gonzalez S, et al: A mammalian micro RNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyl transferases. Nat Strat Mol Biol 15:268–279 (2008).
9.
Blanco R, Munoz P, Flores JM, Klatt P, Blasco MA: Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev 21:206–220 (2007).
10.
Blasco MA, Lee H-W, Hande P, Samper E, Lansdorp P, et al: Telomere shortening and tumour formation by mouse cells lacking telomerase RNA. Cell 91:25–34 (1997).
11.
Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240–4248 (1995).
12.
Cornforth MN, Eberle RL: Termini of human chromosomes display elevated rates of mitotic recombination. Mutagenesis 16:85–89 (2001).
13.
d’Adda diFagagna P, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP: Functions of poly (ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet 23:76–80 (1999).
14.
Espejel S, Klatt P, Menissier de Murcia J, Martin-Caballero J, Flores JM, et al: Impact of telomerase ablation on organismal viability, ageing and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86 or DNA-PKcs. J Cell Biol 167:627–638 (2004).
15.
Ford LP, Zou Y, Pongracz, Gryaznov SM, Shay JW, Wright WE: Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J Biol Chem 276:32198–32203 (2001).
16.
Goodwin E, Meyne J: Strand-specific FISH reveals orientation of chromosome 18 alphoid DNA. Cytogenet Cell Genet 63:126–127 (1993).
17.
Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, et al: Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 192:1625–1636 (2000).
18.
He H, Multani AS, Cosme-Blanco W, Tahara H, Ma J, et al: POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J 25:5180–5190 (2006).
19.
Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, Blasco MA: Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18:2950–2960 (1999).
20.
Jaco I, Canela A, Vera E, Blasco MA: Centromere mitotic recombination in mammalian cells. J Cell Biol 181:885–892 (2008).
21.
Kowalczuk CI, Priestner MC, Pearson AJ, Saunders RD, Bouffler SD: Wavelength dependence of cellular responses in human melanocytes and melanoma cells following exposure to ultraviolet radiation. Int J Radiat Biol 82:781–792 (2006).
22.
Londoño-Vallejo JA, Der-Sarkissian H, Cazes L, Bacchetti S, Reddel RR: Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res 64:2324–2327 (2004).
23.
Menissier de Murcia J, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, et al: Requirement of poly (ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 94:7303–7307 (1997).
24.
Rudd MK, Friedman C, Parghi SS, Linardopoulou EV, Hsu Li, Trask BJ: Elevated rates of sister chromatid exchange at chromosome ends. PLoS Genet 3:e32 (2007).
25.
Siegl-Cachedenier I, Munoz P, Flores JM, Klatt P, Blasco MA: Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres. Genes Dev 21:2239–2247 (2007).
26.
Wang Y, Erdmann N, Giannone RJ, Wu J, Gomez M, Liu Y: An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres. Proc Natl Acad Sci USA 102:10256–10260 (2005a).
27.
Wang Y, Giannone RJ, Liu Y: Telomere sister chromatid exchange in telomerase deficient murine cells. Cell Cycle 4:1320–1322 (2005b).
© 2008 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.